๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation

โœ Scribed by Thami Sebti; Gabrielle Pilcer; Bernard Van Gansbeke; Serge Goldman; Alain Michils; Francis Vanderbist; Karim Amighi

Book ID
116437531
Publisher
Elsevier Science
Year
2006
Tongue
French
Weight
164 KB
Volume
64
Category
Article
ISSN
0939-6411

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Dry powder formulations for inhalation o
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals
โœ Darragh Murnane; Gary P. Martin; Christopher Marriott ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 307 KB

Direct crystallization of active pharmaceutical ingredient (API) particles in the inhalable size range of 1-6 microm may overcome surface energization resulting from micronization. The aerosolization of fluticasone propionate (FP) and salmeterol xinafoate (SX) microcrystals produced by aqueous cryst

Physicochemical characterization and sta
Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation
โœ Changsan, Narumon (author);Chan, Hak Kim (author);Separovic, Frances (author);Sr ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons Inc. ๐ŸŒ English โš– 298 KB

Liposomes were used to encapsulate rifampicin (RIF) as an alternative formulation for delivery to the respiratory tract. Factors affecting the stability of liposomes containing RIF were determined. Four liposome suspensions were prepared, containing different millimole ratios of cholesterol (CH) and